Minnesota), and transaortic for both prostheses.
Despite these options, more than 3% of patients with symptomatic severe aortic stenosis are believed to have anatomic or physiological features making none of these approaches feasible (2) . We report our firstin-man experience and demonstrate the intraprocedural safety of the CV percutaneous aortic valve implantation using the novel retrograde caval-aortic approach in a subgroup of inoperable patients with severe aortic stenosis. We successfully performed TAVR with caval-aortic access in 4 patients with a mean age of 81.5 AE 8.5
years (3 women and 1 man), mean Society of Thoracic
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